<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Jiang WG</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>To investigate the expression of EPLIN-alpha, epithelial protein lost in neoplasm, in human breast cancer tissues/cells and investigate the cellular impact of EPLIN-alpha on breast cancer cells.&lt;h4>Experimental design&lt;/h4>EPLIN-alpha was determined in tumour (n = 120) and normal mammary tissues (n = 32), and cancer cell lines (n = 16). Cell invasion, in vitro and in vivo growth of cells transfected with EPLIN-alpha were evaluated using in vitro invasion assay, in vitro and in vivo tumour model. Cellular migration was analysed using Electric Cell Impedance Sensing assays.&lt;h4>Results&lt;/h4>Low level of EPLIN-alpha was seen in tumour tissues. Grade-2/3 tumours had significantly lower levels of EPLIN-alpha compared with grade-1 (p = 0.047 and p = 0.046 vs grade-1, respective</pubmed_abstract><journal>Molecular cancer</journal><pagination>71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2553413</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.</pubmed_title><pmcid>PMC2553413</pmcid><pubmed_authors>Mansel RE</pubmed_authors><pubmed_authors>Ye L</pubmed_authors><pubmed_authors>Lewis-Russell JM</pubmed_authors><pubmed_authors>Martin TA</pubmed_authors><pubmed_authors>Douglas-Jones A</pubmed_authors><pubmed_authors>Jiang WG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.</name><description>&lt;h4>Introduction&lt;/h4>To investigate the expression of EPLIN-alpha, epithelial protein lost in neoplasm, in human breast cancer tissues/cells and investigate the cellular impact of EPLIN-alpha on breast cancer cells.&lt;h4>Experimental design&lt;/h4>EPLIN-alpha was determined in tumour (n = 120) and normal mammary tissues (n = 32), and cancer cell lines (n = 16). Cell invasion, in vitro and in vivo growth of cells transfected with EPLIN-alpha were evaluated using in vitro invasion assay, in vitro and in vivo tumour model. Cellular migration was analysed using Electric Cell Impedance Sensing assays.&lt;h4>Results&lt;/h4>Low level of EPLIN-alpha was seen in tumour tissues. Grade-2/3 tumours had significantly lower levels of EPLIN-alpha compared with grade-1 (p = 0.047 and p = 0.046 vs grade-1, respective</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Sep</publication><modification>2025-04-05T12:16:02.195Z</modification><creation>2019-06-06T19:49:57Z</creation></dates><accession>S-EPMC2553413</accession><cross_references><pubmed>18796137</pubmed><doi>10.1186/1476-4598-7-71</doi></cross_references></HashMap>